Approval · Notice of Compliance 14774 · 2013
AMOXICILLIN: Notice of Compliance 14774
Issued October 2, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14774
- Date
- October 2, 2013
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Licensing agreement between two companies
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AMOXICILLIN | 02352710 | Dormant |
| AMOXICILLIN | 02352729 | Dormant |
| AMOXICILLIN | 02352745 | Cancelled Post Market |
| AMOXICILLIN | 02352753 | Marketed |
| AMOXICILLIN (SUGAR REDUCED) | 02352761 | Cancelled Post Market |
| AMOXICILLIN (SUGAR REDUCED) | 02352788 | Marketed |
Medicinal ingredients
- AMOXICILLIN TRIHYDRATE 250 MG per CAP
- AMOXICILLIN TRIHYDRATE 500 MG per CAP
- AMOXICILLIN TRIHYDRATE 125 MG per 5ML
- AMOXICILLIN TRIHYDRATE 250 MG per 5ML